RelationshipsVaginal atrophy and GSM: symptoms, treatment and when to seek care
Dryness is only one part of genitourinary syndrome of menopause. Understand burning, painful sex, urinary symptoms, moisturisers, vaginal estrogen and red flags.
Tap a card to reveal the answer. Start here, then read deeper whenever you are ready.
What GSM means
Genitourinary syndrome of menopause, or GSM, describes changes linked with lower estrogen in the vulva, vagina, urethra and bladder. The older term vaginal atrophy focuses too narrowly on tissue thinning. GSM recognises that dryness, sex, comfort and urinary health are connected.
Unlike some hot flushes, GSM often does not simply fade with time. Symptoms may appear in perimenopause or years after the final period and can progress without treatment. It is common and treatable, but burning or pain should not automatically be assumed to be GSM.
Symptoms beyond dryness
Possible symptoms include dryness, burning, itching, irritation, reduced lubrication, tightness, pain with penetration, spotting after sex and a change in sexual comfort. Urinary urgency, frequency, burning, recurrent urinary infections and some leakage can coexist because the urethra and bladder outlet are estrogen-responsive tissues.
Similar symptoms can come from thrush, bacterial infection, sexually transmitted infection, vulval skin disease, allergy, pelvic-floor overactivity, diabetes, Sjögren's syndrome or bladder pain syndrome. Examination and selected testing matter when symptoms are new, persistent, recurrent or atypical.
Moisturisers and lubricants
A vaginal moisturiser is used regularly, often several times weekly according to its label, to support ongoing hydration. A lubricant is used during sexual activity to reduce friction. Some people need both. Choose unscented products and stop if burning worsens. Oil-based products can damage latex condoms, so check compatibility.
Moisturisers and lubricants can improve comfort but do not fully reverse estrogen-related tissue change or reliably treat recurrent urinary infection. Persistent pain may also involve pelvic-floor muscles, fear and anticipation. Pelvic-floor physiotherapy or psychosexual support can be valuable alongside tissue treatment.
Low-dose vaginal estrogen
Vaginal estrogen is available as creams, tablets or pessaries and rings in different markets. It delivers a low dose directly to local tissue and usually has much lower systemic absorption than systemic HRT. It can improve dryness, burning, painful sex and some urinary symptoms. Benefits may build over weeks, and symptoms often return if treatment stops.
Most people do not need a progestogen solely for low-dose vaginal estrogen, but the exact product and history matter. Unexplained vaginal bleeding requires assessment. People with a history of hormone-sensitive cancer should discuss non-hormonal options and local estrogen with their oncology and menopause teams rather than receiving an automatic yes or no.
Other treatments and recurrent UTI
Where available, vaginal DHEA or oral ospemifene may be considered for selected symptoms and individuals. Availability, contraindications and evidence differ. Laser and energy-based vaginal devices are marketed widely, but major professional guidance has called for stronger evidence and clear discussion of uncertainty, cost and adverse effects.
Recurrent urinary burning should be tested rather than repeatedly treated by guesswork. Confirmed recurrent UTI may need a prevention plan that includes hydration, addressing GSM, and selected antibiotic or non-antibiotic strategies according to medical history. Fever, flank pain, vomiting or feeling severely unwell can signal kidney infection and needs prompt care.
Sex, communication and examination
Painful sex is a health symptom, not a measure of attraction or relationship quality. Pause painful penetration, remove performance pressure and allow time for arousal. A partner can help by listening, using lubricant, respecting a pause and supporting treatment rather than treating pain as rejection.
A clinician may inspect the vulva and vagina, assess pelvic-floor tenderness and test discharge or urine when indicated. You can request a female clinician, chaperone, explanation before each step and a pause at any time. Trauma-informed care and consent apply to every examination.
Red flags
Arrange prompt assessment for any bleeding after menopause, repeated bleeding after sex, a new vulval lump, sore or colour change, persistent unusual discharge, pelvic pain or symptoms that do not improve. Seek urgent care for heavy bleeding with dizziness, severe pelvic pain, fever with flank pain, inability to pass urine or signs of a serious allergic reaction.
Frequently asked questions
Is vaginal atrophy the same as GSM?
Vaginal atrophy describes tissue change; GSM is the broader modern term covering vulval, vaginal and urinary symptoms.
Does it go away naturally?
It often persists or progresses without treatment.
Is vaginal estrogen the same as systemic HRT?
No. Low-dose local therapy has much lower systemic exposure and a different risk discussion.
Can GSM feel like a UTI?
Yes. Testing helps distinguish infection from GSM and other causes.
Is bleeding normal with dryness?
Do not assume it is normal, especially after menopause; arrange assessment.
Sources behind this guide
- ACOG: Vaginitis and GSM ↗
- ACOG: Vaginal dryness ↗
- NHS: Vaginal dryness ↗
- NHS: About vaginal oestrogen ↗
- NICE: Menopause identification and management ↗
- Indian Menopause Society 2026 clinical practice recommendations ↗
Editorial foundation: Stri.life research guides, Menopause in India Overview and Comprehensive Guide to Perimenopause, reviewed August 2026.
Conversation 0